Elevated levels of endothelin-1 and prostaglandin E2 and their effect on nitric oxide generation in placental tissue from neonatal streptozotocin-induced diabetic rats

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 68, Issue 3, 2003, Pages 225-231

  Capobianco, E ^a   Jawerbaum, A ^a   White, V ^a   Pustovrh, C ^a   Sinner, D ^a   Gonzalez, E T ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FETOPLACENTAL UNIT; FETUS HYPOXIA; NEWBORN; NONHUMAN; PLACENTA INSUFFICIENCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASOCONSTRICTION;

EID: 0037369180     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(02)00274-0     Document Type: Article

References (40)

1. D.B. Singer, J.A. Widnes, C.T. Liu, R.A. Ellis, Placentas in pregnancies complicated by maternal diabetes mellitus, Surv. Synth. Pathol. Res. 3 (1984) 333-341.
2. O. Bjork, B. Persson, Placental changes in relation to the degree of metabolic control in diabetes mellitus, Placenta 3 (1982) 367-372.
3. K. Bernischke, P. Kaufman, Pathology of the Human Placenta, Second Edition, Springer, New York, 1990, pp. 475-479.
4. M.S. Al-Okail, O.S. Al-Attas, Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic patientes, Endocrinol. Jpn. 41 (1994) 355-360.
5. N.C. Chartrel, M.T. Clabaut, F.A. Boismare, J.C. Scrub, Uteroplacental hemodynamic disturbances in establishment of fetal growth retardation in streptozotocin-induced diabetic rats, Diabetes 39 (1990) 743-746.
6. S. Caritis, B. Sibai, K. Hauth, M.D. Lindhelmer, M. Kebanoff, E. Thom, P. VanDorsten, M. Landon, R. Paul, M. Miodovnik, P. Meis, G. Thurnau, Low dose aspirin to prevent preeclampsia in women at high risk, N. Engl. J. Med. 338 (1998) 701-705.
7. B. Portha, L. Picon, G. Rosselin, Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes, Diabetologia 17 (1979) 371-377.
8. B.L. Mallof, B.K. Boyd, Physiologic and cellular insulin action in a glucose-intolerant model of type 2 (non-insulin-dependent) diabetes in rats, Diabetologia 29 (1986) 295-300.
9. N. Tridau, B. Portha, L. Picon, G. Rosselin, Experimental chemical diabetes and pregnancy in the rat, Diabetes 31 (1982) 75-79.
10. A. Jawerbaum, J. Roselló-Catafau, E.T. Gonzalez, V. Novaro, G. Gomez, E. Gelpi, A. Vitullo, M.A.F. Gimeno, Eicosanoid production, metabolism and contractile activity in the isolated uterus from non-insulin-dependent diabetic rats during late pregnancy, Prostaglandins 51 (1996) 307-320.
11. A. Jawerbaum, V. Novaro, A.M. Franchi, M. Gimeno, E. Gonzalez, High glucose levels modulate eicosanoid production in uterine and placental tissue from non-insulin-dependent diabetic rats during late pregnancy, Prostaglandins Leukot. Essent. Fatty Acids 58 (1998) 389-393.
12. 2α production and the nitridergic system during embryonic implantation in the rat, Prostaglandins 51 (1996) 363-376.
13. E. Gonzalez, A. Jawerbaum, V. Novaro, D. Sinner, M. Gimeno, Nitric oxide modulates placental prostanoid production from late pregnant non-insulin-dependent diabetic rat, Prostaglandins Leukot. Essent. Fatty Acids 59 (1998) 299-304.
14. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, T. Masaki, A novel vasoconstrictor peptide produced by vascular endothelial cells, Nature 332 (1998) 411-415.
15. H.E. Norman, I.T. Cameron, Nitric oxide in the human uterus, Rev. Reproduct. 1 (1996) 61-68.
16. B.V. Sastry, M.E. Hemontolor, M.B. Chance. R.F. Johnson, Dual messenger function for prostaglandin E2 (PGE2) in human placenta, Cell Mol. Biol. 43 (1997) 417-424.
17. M. Trybulec, R.R. Dudek, R.J. Gryglewski, Effects of endothelin-1 and endothelin-3 on the release of prostanoids from isolated perfused rat kidney, J. Cardiovasc. Pharmacol. 17 (1991) S229-232.
18. S. Hyslop, G. De Nucci, Vasoactive mediators released by endothelins. Pharmacol. Res. 26 (1992) 223-230.
19. E. Gonzalez, A. Jawerbaum, D. Sinner, C. Pustovrh, C. Xaus, C. Peralta, G. Gomez, J. Rosello-Catafau, E. Gelpi, M.A.F. Gimeno, Evolution of streptozotocin-pancreatic damage in the rat: modulatory effect of endothelins on the nitridergic and prostanoid pathway, Nitric oxide 3 (1999) 459-466.
20. H. Vierhapper, O. Wagner, P. Nowotny, W. Waldhausl, Effect of endothelin-1 in man, Circulation 81 (1990) 1415-1418.
21. H.J. Singh, A. Rahman, E.T. Larmie, A. Nila, Endothelin-1 in feto-placental tissues from normotensive pregnant women and women with pre-eclampsia, Acta Obstet. Gynecol. Scand. 80 (2001) 99-103.
22. L.G. Thaete, M.G. Neerhof, M.S. Caplan, Endothelin receptor A antagonism prevents hypoxia-induced intrauterine growth restriction in the rat, Am. J. Obstet. Gynecol. 176 (1997) 73-76.
23. M. Fukui, T. Nakamura, I. Ebihara, S. Oisada, Y. Tomino, T. Masaki, K. Goto, Y. Furuichi, H. Koide, Gene expression for endothelins and their receptors in glomeruli of diabetic rats, J. Lab. Clin. Med. 122 (1993) 149-156.
24. Y. Takeda, I. Miyamori, T. Yoneda, R. Takeda, Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats, Life Sci. 48 (1991) 2553-2556.
25. M. Clozel, V. Breu, G.A. Gray, B. Kalina, B.M. Loffler, K. Burri, J.M. Cassal, G. Hith, M. Muller, W. Neidhart, Pharmacological characterization of bosentan: a new potent orally active nonpeptide endothelin receptor antagonist, J. Pharmacol. Exp. Ther. 270 (1994) 228-235.
26. 15N-nitrate in biological fluids, Anal. Biochem. 126 (1982) 131-138.
27. R.L. Hopfner, V. Gopalakrishnan, Endothelin: emerging role in diabetic vascular complications, Diabetologia 42 (1999) 1383-1394.
28. E. Morabito, N. Corsico, S. Serafini, E.A. Martelli, Elevated utinary excretion of endothelins in streptozotocin-diabetic rats, Life Sci. 54 (1994) PL197-PL200.
29. E. Lawrence, S.L. Brain, Altered microvascular reactivity to endothelin-1 endothelin-3 and NG-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus, Br. J. Pharmacol. 106 (1992) 1035-1040.
30. B.G. Seligman, A. Biolo, C.A. Polanczyk, J.L. Gross, N. Clausell, Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipemia, Diabetes Care 23 (2000) 1395-1400.
31. D. Sinner, A. Jawerbaum, C. Pustovrh, V. White, E. Capobianco, E. Gonzalez, Levels of endothelin-1 in embryos from control and neonatal-streptozotocin diabetic rats, and their relationship with nitric oxide generation, Reprod. Fertil. Dev. 14 (2002) 23-28.
32. M.D. Mitchell, R.J. Romero, R. Lepera, L. Rittenhouse, S.S. Edwin, Actions of endothelin-1 on prostaglandin production by gestational tissues, Prostaglandins 40 (1990) 627-635.
33. T. Ohno, M. Katori, M. Majina, T. Saeki, K. Boku, K. Nishiyama, H. Hayashi, K. Saigenji, Dilatation and constriction of rat gastric mucosal microvessels through prostaglandin EP2 and EP3 receptors, Aliment. Pharmacol. Ther. 13 (1999) 1243-1250.
34. L. Walch, V. Montpreville, C. Brink, X. Norel, Prostanoid EP(1)-and TP-receptors involved in the contraction of human pulmonary veins, Br. J. Pharmacol. 134 (2001) 1671-1678.
35. D. Abran, I. Dumont, P. Hardy, K. Peri, D.Y. Li, S. Molotchnikoff, D.R. Varma, S. Chemtob, Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development, Circ. Res. 80 (1997) 604-606.
36. G. Shonfelder, M. John, H. Hopp, A. Fuhr, M. VanDerGiet, M. Paul, Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes, FASEB J. 10 (1996) 777-784.
37. W.G. Rossmanith, U. Hoffmeister, S. Wolfahrt, B. Kleine, M. Mc Lean, R.A. Jacobs, A.B. Grossman, Expression and functional analysis of endothelian nitric oxide synthase in human placenta, Mol. Hum. Reprod. 5 (1999) 487-494.
38. Pustovrh, C., Jawerbaum, A., Sinner, D., Pesaresi, M., Baier, M., Gimeno, M., Gonzalez, E., Membrane-type matrix Metalloproteinase-9 Activity in placental tissue from patients with pregestational and gestational diabetes mellitus, Reprod. Fertil. Dev. 12 269-275.
39. V. Novaro, A. Jawerbaum, A. Faletti, M. Gimeno, E. González, Embryo implantation in type IT diabetes in the rat, Reprod. Fertil. Dev. 10 (1998) 217-223.
40. M. Napolitano, F. Miceli, A. Calce, A. Vacca, A. Gulino, R. Apa, A. Lanzone, Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas, J. Clin. Endocrino. Metab. 85 (2000) 2318-2323.